Tayu Huaxia Biotech Medical Group Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Tayu Huaxia Biotech Medical Group Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas (NCT04458389) | Tayu Huaxia Biotech Medical Group Co., Ltd. | 2020-12-07 |
Track Tayu Huaxia Biotech Medical Group Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.